Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study
Saved in:
| Published in: | Open Access Journal of Urology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301678917615617 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Open Access Journal of Urology |
| description | |
| discipline_display | Urology, Nephrology and Andrology |
| discipline_facet | Urology, Nephrology and Andrology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:57495 |
| institution | FRELIP |
| journal_source_facet | Open Access Journal of Urology |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Urology, Nephrology and Andrology General Urology, Nephrology and Andrology Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| subject_facet | Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| title | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_auth | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_full | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_fullStr | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_full_unstemmed | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_short | Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study |
| title_sort | early progressive disease during nivolumab plus ipilimumab therapy predicts poor survival in japanese patients with advanced renal cell carcinoma: a single-center 12-week landmark study |
| topic | Urology, Nephrology and Andrology General Urology, Nephrology and Andrology |
| url | https://www.dovepress.com/early-progressive-disease-during-nivolumab-plus-ipilimumab-therapy-pre-peer-reviewed-fulltext-article-RRU |